AGT - angiotensinogen Gene
Also Known as ANHU; hFLT1; SERPINA8
Species: Homo sapiens
About AGT
This gene has 13 transcripts (splice variants), 194 orthologues, 36 paralogues and is associated with 5 phenotypes. Biased expression in liver (RPKM 264.6), brain (RPKM 76.5) and 3 other tissues.
Summary
The protein encoded by this gene, pre-angiotensinogen or Angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme Renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure, body fluid and electrolyte homeostasis, and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease. [provided by RefSeq, Nov 2019]
AGT Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001382817.3 | NP_001369746.2 | angiotensinogen precursor |
| NM_001384479.1 | NP_001371408.1 | angiotensinogen precursor |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables hormone activity |
IDA
IDA: Inferred from direct assay
|
1567413 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
10969042 | GOA |
| enables receptor ligand activity |
IDA
IDA: Inferred from direct assay
|
24296617 | GOA |
| enables sodium channel regulator activity |
IMP
IMP: Inferred from mutant phenotype
|
15803439 | GOA |
| enables type 1 angiotensin receptor binding |
IPI
IPI: Inferred from physical interaction
|
1378723 | GOA |
| enables type 2 angiotensin receptor binding |
IPI
IPI: Inferred from physical interaction
|
10406457 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| is active in extracellular space |
IDA
IDA: Inferred from direct assay
|
4300938 | GOA |
| located in extracellular space |
IDA
IDA: Inferred from direct assay
|
18971559 | GOA |
AGT Protein Structure
Serpin: Serpin (serine protease inhibitor) (114 - 481)
- 0
- 100
- 200
- 300
- 400
- 485 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
angiotensinogen |
|
AGT Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
AGT | P01019 | SNX12 | Homo sapiens | Q9UMY4 | 32814053 | |
|
Intra
|
AGT | P01019 | SNX12 | Homo sapiens | Q9UMY4 | 32814053 | |
|
Intra
|
AGT | P01019 | SNX12 | Homo sapiens | Q9UMY4 | 32814053 | |
|
Intra
|
AGT | P01019 | TMEM185A | Homo sapiens | Q8NFB2 | 32814053 | |
|
Intra
|
AGT | P01019 | TMEM185A | Homo sapiens | Q8NFB2 | 32814053 | |
|
Intra
|
AGT | P01019 | TMEM185A | Homo sapiens | Q8NFB2 | 32814053 | |
|
Intra
|
AGT | P01019 | EIF2B4 | Homo sapiens | Q9UI10 | 32814053 | |
|
Intra
|
AGT | P01019 | EIF2B4 | Homo sapiens | Q9UI10 | 32814053 | |
|
Intra
|
AGT | P01019 | EIF2B4 | Homo sapiens | Q9UI10 | 32814053 | |
|
Intra
|
AGT | P01019 | NPHP1 | Homo sapiens | C9J082 | 32814053 | |
|
Intra
|
AGT | P01019 | NPHP1 | Homo sapiens | C9J082 | 32814053 | |
|
Intra
|
AGT | P01019 | NPHP1 | Homo sapiens | C9J082 | 32814053 | |
|
Intra
|
AGT | P01019 | TGOLN2 | Homo sapiens | O43493-5 | 32814053 | |
|
Intra
|
AGT | P01019 | TGOLN2 | Homo sapiens | O43493-5 | 32814053 | |
|
Intra
|
AGT | P01019 | TGOLN2 | Homo sapiens | O43493-5 | 32814053 | |
|
Intra
|
AGT | P01019 | SLFN12 | Homo sapiens | Q8IYM2 | 32814053 | |
|
Intra
|
AGT | P01019 | SLFN12 | Homo sapiens | Q8IYM2 | 32814053 | |
|
Intra
|
AGT | P01019 | SLFN12 | Homo sapiens | Q8IYM2 | 32814053 | |
|
Intra
|
AGT | P01019 | PRMT5 | Homo sapiens | O14744 | 32814053 | |
|
Intra
|
AGT | P01019 | PRMT5 | Homo sapiens | O14744 | 32814053 | |
|
Intra
|
AGT | P01019 | PRMT5 | Homo sapiens | O14744 | 32814053 | |
|
Intra
|
AGT | P01019 | NME4 | Homo sapiens | O00746 | 32814053 | |
|
Intra
|
AGT | P01019 | NME4 | Homo sapiens | O00746 | 32814053 | |
|
Intra
|
AGT | P01019 | NME4 | Homo sapiens | O00746 | 32814053 | |
|
Cross
|
AGT | P01019 | Agtr1 | Rattus norvegicus | P25095 | 18202720 |
Recombinant AGT Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P72477 | Serpin A8/Angiotensinogen Protein, Human (HEK293, His, solution) | AAH11519.1 (D34-A485) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P73653 | Serpin A8/Angiotensinogen Protein, Human (HEK293, His) | NP_000020.1 (D34-A485) | ≥ 95%, as determined by reducing SDS-PAGE. |
AGT Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P83896 | AGT Antibody (YA3593) | WB, ELISA | Human |
| HY-P83896A | AGT Antibody (YA3593)(PBS only) | WB, ELISA | Human |
| HY-P89537 | Angiotensin I Antibody (YA8881) | ELISA | human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Renal Tubular Dysgenesis |
|
|
| Hypertension, Essential |
|
|
| Pre-Eclampsia |
|
|
| Anuria |
|
|
| Atrial Fibrillation |
|
|
| Renal Fibrosis |
|
|
| Heart Disease |
|
|
| Oligohydramnios |
|
|
| Covid-19 |
|
|
| Fibromuscular Dysplasia |
|
|
| Obstructive Nephropathy |
|
|
| Vesicoureteral Reflux |
|
|
| Gitelman Syndrome |
|
|
| Potter'S Syndrome |
|
|
| Sick Sinus Syndrome |
|
|
| Congestive Heart Failure |
|
|
| Multicystic Dysplastic Kidney |
|
|
| Vascular Disease |
|
|
| Kidney Disease |
|
|
| Cerebrovascular Disease |
|
|
| Eclampsia |
|
|
| Otosclerosis |
|
|
| Cardiovascular System Disease |
|
|
| Sleep Apnea |
|
|
| Myocardial Infarction |
|
|
| Apnea, Obstructive Sleep |
|
|
| Lipoprotein Quantitative Trait Locus |
|
|
| Type 2 Diabetes Mellitus |
|
|
| Inflammatory Bowel Disease |
|
|
| Pulmonary Edema |
|
|
| Iga Glomerulonephritis |
|
|
| Type 1 Diabetes Mellitus |
|
|
| Renal Hypertension |
|
|
| Renovascular Hypertension |
|
|
| Fabry Disease |
|
|
| Renal Artery Disease |
|
|
| Focal Segmental Glomerulosclerosis |
|
|
| Atherosclerosis Susceptibility |
|
|
| Nephrotic Syndrome |
|
|
| Microvascular Complications Of Diabetes 1 |
|
|
| Conn'S Syndrome |
|
|
| Pulmonary Hypertension |
|
|
| Hyperaldosteronism, Familial, Type I |
|
|
| Diabetes Mellitus |
|
|
| Microvascular Complications Of Diabetes 5 |
|
|
| Chronic Kidney Disease |
|
|
| Liddle Syndrome 1 |
|
|
| Alcohol Dependence |
|
|
| Plantar Fascial Fibromatosis |
|
|
| Essential Thrombocythemia |
|
|
| Aortic Valve Disease 2 |
|
|
| Interstitial Lung Disease 2 |
|
|
| Malignant Secondary Hypertension |
|
|
| Cerebral Palsy |
|
|
| Body Mass Index Quantitative Trait Locus 11 |
|
|
| Stroke, Ischemic |
|
|
| Autosomal Dominant Polycystic Kidney Disease |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Macaca mulatta | AGT | VGNC | VGNC:69751 |
| Bos taurus | AGT | VGNC | VGNC:103718 |
| Rattus norvegicus | AGT | RGD | RGD:2069 |
| Canis familiaris | AGT | VGNC | VGNC:37718 |
| Mus musculus | AGT | MGD | MGI:87963 |
| Others | AGT | NCBI |